Skip to main content

Aurora Spine Corporation(ASG-X)
TSX Venture

Today's Change
Delayed Last Update

Aurora Spine Corporation

20 Holly Street
Suite 300
Toronto ON M4S 3B1 CAN
P: 416-486-9800
F: 416-486-3309
https://www.aurora-spine.com

Sectors & Indices

Sector
Industry
Employees

Profile

Aurora Spine Corp is engaged in the development, manufacture, and selling of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.

Key Executives

NameTitle
Trent J. NorthcuttCEO/Director/Founder/President
Chad ClouseCFO

More from The Globe

Canaccord reworks U.S. leadership in wake of regulatory settlement
The logo for Canaccord Genuity is shown in Toronto on Wednesday, March 8, 2023. THE CANADIAN PRESS/Staff
Bullish on FirstEnergy Corp.
Monica Rizk
The most oversold and overbought stocks on the TSX
The Bay Street Financial District is shown with the Canadian flag in Toronto on Friday, August 5, 2022.
Monday’s analyst upgrades and downgrades
A Dollarama store is seen Tuesday, June 11, 2013 in Montreal. Dollarama Inc. raised its quarterly dividend by 10 per cent as it reported its fourth-quarter profit and sales rose compared with a year ago. THE CANADIAN PRESS/Paul Chiasson
opinion
Why are Canadian bank valuations so low?
Tom Bradley
number cruncher
Eleven U.S. semiconductor stocks showing strength
For Number Cruncher column in Globe Investor/ROB only.
Wednesday’s analyst upgrades and downgrades
An office building for Goeasy Ltd, a personal lender for subprime borrowers, in Mississauga, Ontario, on March 10, 2026.
Bullish on Archer-Daniels-Midland Co.
Monica Rizk

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.